{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:36:30Z","timestamp":1792046190443,"version":"4.4.0"},"reference-count":172,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010428","name":"Innovation and Technology Fund","doi-asserted-by":"publisher","award":["UIM\/198"],"award-info":[{"award-number":["UIM\/198"]}],"id":[{"id":"10.13039\/501100010428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["HKUST 660810"],"award-info":[{"award-number":["HKUST 660810"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["661111"],"award-info":[{"award-number":["661111"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["T13-607\/12R"],"award-info":[{"award-number":["T13-607\/12R"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012234","name":"Shenzhen Peacock Plan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2013CB530900"],"award-info":[{"award-number":["2013CB530900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.neuint.2015.07.018","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T10:42:11Z","timestamp":1437907331000},"page":"260-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":207,"special_numbering":"C","title":["Plant alkaloids as drug leads for Alzheimer's disease"],"prefix":"10.1016","volume":"89","author":[{"given":"Yu Pong","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry Cho Tsun","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Y.","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2015.07.018_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1472-6882-13-218","article-title":"In\u00a0vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects","volume":"13","author":"Abd El-Wahab","year":"2013","journal-title":"BMC Complement. Altern. Med."},{"issue":"25","key":"10.1016\/j.neuint.2015.07.018_bib2","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuint.2015.07.018_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2741\/4285","article-title":"An update on drug treatment options of Alzheimer's disease","volume":"19","author":"Allgaier","year":"2014","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"5","key":"10.1016\/j.neuint.2015.07.018_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/092986708783503203","article-title":"Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction","volume":"15","author":"Amenta","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"0","key":"10.1016\/j.neuint.2015.07.018_bib5","doi-asserted-by":"crossref","first-page":"xlviii","DOI":"10.1016\/j.phytol.2014.06.015","article-title":"Alkaloids as drug leads \u2013 a predictive structural and biodiversity-based analysis","volume":"10","author":"Amirkia","year":"2014","journal-title":"Phytochem. Lett."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-2009-1087","article-title":"Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice","volume":"17","author":"Arendash","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2006.11.043","article-title":"Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease abeta secretion","volume":"352","author":"Asai","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","article-title":"Follow-up evaluation of cognitive function in the randomized Alzheimer's disease anti-inflammatory prevention trial and its follow-up study","volume":"11","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.neuint.2015.07.018_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0006-3223(94)90047-7","article-title":"In\u00a0vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI","volume":"35","author":"Bartzokis","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2015.07.018_bib10","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.2147\/IJN.S35333","article-title":"Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by A\u03b21-42 in Alzheimer's disease models","volume":"7","author":"Bernardi","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.neuint.2015.07.018_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0028-3908(91)90005-V","article-title":"Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice","volume":"30","author":"Bickel","year":"1991","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1474-9728.2004.00101.x","article-title":"How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes","volume":"3","author":"Blasko","year":"2004","journal-title":"Aging Cell"},{"issue":"9533","key":"10.1016\/j.neuint.2015.07.018_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.neuint.2015.07.018_bib14","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/jphp.12172","article-title":"Berberis aetnensis and B.\u2009libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity","volume":"65","author":"Bonesi","year":"2013","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0022-3565(25)12928-5","article-title":"Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine","volume":"277","author":"Bores","year":"1996","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","article-title":"The metallobiology of Alzheimer's disease","volume":"26","author":"Bush","year":"2003","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib18","first-page":"126","article-title":"Inhibitory effect of rhynchophylline on platelet aggregation and thrombosis","volume":"13","author":"Chen","year":"1992","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11011-014-9580-x","article-title":"Berberine protects homocysteic acid-induced HT-22 cell death: involvement of Akt pathway","volume":"30","author":"Chen","year":"2015","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib20","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.foodchem.2012.04.148","article-title":"Crude caffeine reduces memory impairment and amyloid \u03b2(1-42) levels in an Alzheimer's mouse model","volume":"135","author":"Chu","year":"2012","journal-title":"Food Chem."},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.neubiorev.2011.03.001","article-title":"Revisiting the cholinergic hypothesis in the development of Alzheimer's disease","volume":"35","author":"Craig","year":"2011","journal-title":"Neurosci. Biobehav Rev."},{"issue":"5","key":"10.1016\/j.neuint.2015.07.018_bib22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijantimicag.2014.06.001","article-title":"Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities","volume":"44","author":"Cushnie","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25\u201335)-induced cognitive deficits in mice","volume":"203","author":"Dall'Igna","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2015.07.018_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","article-title":"Alzheimer's disease","volume":"65","author":"De-Paula","year":"2012","journal-title":"Subcell. Biochem."},{"issue":"17","key":"10.1016\/j.neuint.2015.07.018_bib25","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1021\/ol301951r","article-title":"An efficient total synthesis of (-)-huperzine A","volume":"14","author":"Ding","year":"2012","journal-title":"Org. Lett."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.nbd.2010.03.022","article-title":"Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease","volume":"39","author":"Ding","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib27","doi-asserted-by":"crossref","first-page":"e92954","DOI":"10.1371\/journal.pone.0092954","article-title":"Effects of huanglian-Jie-Du-Tang and its modified formula on the modulation of amyloid-\u03b2 precursor protein processing in Alzheimer's disease models","volume":"9","author":"Durairajan","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neuint.2015.07.018_bib28","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1016\/j.neurobiolaging.2012.02.016","article-title":"Berberine ameliorates \u03b2-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model","volume":"33","author":"Durairajan","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib29","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-2011-102136","article-title":"Cotinine reduces amyloid-\u03b2 aggregation and improves memory in Alzheimer's disease mice","volume":"24","author":"Echeverria","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib30","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.neuropharm.2011.10.022","article-title":"Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia\/reoxygenation","volume":"62","author":"Egea","year":"2012","journal-title":"Neuropharmacology"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuint.2015.07.018_bib31","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.3233\/JAD-2010-1404","article-title":"Caffeine as a protective factor in dementia and Alzheimer's disease","volume":"20","author":"Eskelinen","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2174\/156720511796717258","article-title":"Mechanisms of tau self-aggregation and neurotoxicity","volume":"8","author":"Far\u00edas","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.neuint.2015.07.018_bib33","doi-asserted-by":"crossref","first-page":"e19264","DOI":"10.1371\/journal.pone.0019264","article-title":"\u03b2-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites","volume":"6","author":"Frost","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol. Rev."},{"issue":"27","key":"10.1016\/j.neuint.2015.07.018_bib35","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1405803111","article-title":"Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease","volume":"111","author":"Fu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/jnr.20791","article-title":"Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism","volume":"83","author":"Gao","year":"2006","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"11","key":"10.1016\/j.neuint.2015.07.018_bib37","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.freeradbiomed.2009.02.028","article-title":"Huperzine A protects isolated rat brain mitochondria against beta-amyloid peptide","volume":"46","author":"Gao","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"21","key":"10.1016\/j.neuint.2015.07.018_bib38","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1111\/j.1742-4658.2009.07346.x","article-title":"Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation","volume":"276","author":"G\u00f6ckler","year":"2009","journal-title":"FEBS J."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuint.2015.07.018_bib39","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/jat.805","article-title":"The NMDA receptor ion channel: a site for binding of Huperzine A","volume":"21","author":"Gordon","year":"2001","journal-title":"J.\u00a0Appl. Toxicol."},{"key":"10.1016\/j.neuint.2015.07.018_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fneur.2013.00167","article-title":"Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs","volume":"4","author":"Guzm\u00e1n-Martinez","year":"2013","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0163-7258(95)02002-0","article-title":"The pharmacology of galanthamine and its analogues","volume":"68","author":"Harvey","year":"1995","journal-title":"Pharmacol. Ther."},{"issue":"2\u20133","key":"10.1016\/j.neuint.2015.07.018_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jep.2004.02.012","article-title":"Galanthamine from snowdrop\u2013the development of a modern drug against Alzheimer's disease from local caucasian knowledge","volume":"92","author":"Heinrich","year":"2004","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/156720511795256099","article-title":"Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease","volume":"8","author":"Heneka","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1017\/S1041610201007888","article-title":"Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia","volume":"13","author":"Howe","year":"2001","journal-title":"Int. Psychogeriatr."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1142\/S0192415X09006898","article-title":"Uncaria rhynchophylla and Rhynchophylline inhibit c-Jun N-terminal kinase phosphorylation and nuclear factor-kappaB activity in kainic acid-treated rats","volume":"37","author":"Hsieh","year":"2009","journal-title":"Am. J. Chin. Med."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib48","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bmc.2012.11.044","article-title":"Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors","volume":"21","author":"Hu","year":"2013","journal-title":"Bioorg Med. Chem."},{"issue":"5","key":"10.1016\/j.neuint.2015.07.018_bib49","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neurobiolaging.2013.11.004","article-title":"Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease","volume":"35","author":"Huang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2015.07.018_bib50","series-title":"Compendium of Chemical Terminology, (The \u201cGold Book\u201d)","author":"IUPAC","year":"1997"},{"issue":"10","key":"10.1016\/j.neuint.2015.07.018_bib51","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.2042-7158.2012.01529.x","article-title":"Berberine suppresses amyloid-beta-induced inflammatory response in microglia by inhibiting nuclear factor-kappaB and mitogen-activated protein kinase signalling pathways","volume":"64","author":"Jia","year":"2012","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-121837","article-title":"Capsaicin ameliorates stress-induced Alzheimer's disease-like pathological and cognitive impairments in rats","volume":"35","author":"Jiang","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.neuint.2015.07.018_bib53","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1248\/bpb.32.1433","article-title":"Anti-Alzheimer and antioxidant activities of coptidis rhizoma alkaloids","volume":"32","author":"Jung","year":"2009","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","article-title":"Alzheimer's disease genetics: from the bench to the clinic","volume":"83","author":"Karch","year":"2014","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0301-0082(97)00028-2","article-title":"The cholinergic system in Alzheimer's disease","volume":"52","author":"K\u00e1sa","year":"1997","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.neuint.2015.07.018_bib56","first-page":"548","article-title":"In\u00a0vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines","volume":"59","author":"Kettmann","year":"2004","journal-title":"Pharmazie"},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib57","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2004.10.132","article-title":"Galantamine modulates nicotinic receptor and blocks abeta-enhanced glutamate toxicity","volume":"325","author":"Kihara","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000371710","article-title":"Caffeine intake from coffee or tea and cognitive disorders: a meta-analysis of observational studies","volume":"44","author":"Kim","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"12","key":"10.1016\/j.neuint.2015.07.018_bib59","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1017\/S1461145714000613","article-title":"Galantamine promotes adult hippocampal neurogenesis via M\u2081 muscarinic and \u03b17 nicotinic receptors in mice","volume":"17","author":"Kita","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.neuint.2015.07.018_bib60","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/jphp.12090","article-title":"Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"65","author":"Konrath","year":"2013","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","article-title":"Deciphering the mechanism underlying late-onset Alzheimer disease","volume":"9","author":"Krstic","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A\u00a0review on Alzheimer's disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib63","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0024-3205(02)02200-2","article-title":"A\u00a0comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish berberis species","volume":"72","author":"K\u00fcpeli","year":"2002","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.neuint.2015.07.018_bib64","doi-asserted-by":"crossref","first-page":"e107129","DOI":"10.1371\/journal.pone.0107129","article-title":"Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury","volume":"9","author":"Kysenius","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.neuint.2015.07.018_bib65","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","article-title":"Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology","volume":"35","author":"Laurent","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2015.07.018_bib66","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroscience.2012.12.013","article-title":"Endogenous morphine and its metabolites in mammals: history, synthesis, localization and perspectives","volume":"233","author":"Laux-Biehlmann","year":"2013","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.neuint.2015.07.018_bib67","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1023\/A:1022419712453","article-title":"The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems","volume":"23","author":"Lawrence","year":"1998","journal-title":"Neurochem. Res."},{"issue":"6\u20137","key":"10.1016\/j.neuint.2015.07.018_bib68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.euroneuro.2006.10.006","article-title":"Drug addiction: pathways to the disease and pathophysiological perspectives","volume":"17","author":"Le Moal","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase kinase-3 beta and CDK5\/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?","volume":"276","author":"Leclerc","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"issue":"51","key":"10.1016\/j.neuint.2015.07.018_bib70","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1021\/jp209776x","article-title":"Uric and 1-methyluric acids: metabolic wastes or antiradical protectors?","volume":"115","author":"Leon-Carmona","year":"2011","journal-title":"J.\u00a0Phys. Chem. B"},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib71","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.canlet.2005.08.024","article-title":"Berberine-antiproliferative activity in\u00a0vitro and induction of apoptosis\/necrosis of the U937 and B16 cells","volume":"239","author":"Letasiov\u00e1","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neuint.2015.07.018_bib72","first-page":"CD005592","article-title":"Huperzine A for Alzheimer's disease","volume":"2","author":"Li","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.neuint.2015.07.018_bib73","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00210-013-0888-6","article-title":"Rhynchophylline-induced vasodilation in human mesenteric artery is mainly due to blockage of L-type calcium channels in vascular smooth muscle cells","volume":"386","author":"Li","year":"2013","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"issue":"47","key":"10.1016\/j.neuint.2015.07.018_bib74","doi-asserted-by":"crossref","first-page":"49523","DOI":"10.1074\/jbc.M402034200","article-title":"Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway","volume":"279","author":"Liao","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib75","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1139\/v86-137","article-title":"The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity","volume":"64","author":"Liu","year":"1986","journal-title":"Can. J. Chem."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib76","doi-asserted-by":"crossref","first-page":"e93974","DOI":"10.1371\/journal.pone.0093974","article-title":"Berberine attenuates axonal transport impairment and axonopathy induced by calyculin A in N2a cells","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2015.07.018_bib77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.freeradbiomed.2015.02.028","article-title":"Molecular mechanisms linking amyloid \u03b2 toxicity and Tau hyperphosphorylation in Alzheimer\u05f3s disease","volume":"83","author":"Lloret","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib78","doi-asserted-by":"crossref","first-page":"e40262","DOI":"10.1371\/journal.pone.0040262","article-title":"Multi-target drugs: the trend of drug research and development","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib79","first-page":"238","article-title":"Cerebral protective effects of some compounds isolated from traditional Chinese herbs","volume":"24","author":"Ma","year":"1999","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.neuint.2015.07.018_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2013.02.026","article-title":"Huperzine A promotes hippocampal neurogenesis in\u00a0vitro and in\u00a0vivo","volume":"1506","author":"Ma","year":"2013","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.neuint.2015.07.018_bib81","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.phytochem.2008.04.017","article-title":"In\u00a0vitro production of huperzine A, a promising drug candidate for Alzheimer's disease","volume":"69","author":"Ma","year":"2008","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jep.2007.05.030","article-title":"Huperzine A from Huperzia species\u2013an ethnopharmacolgical review","volume":"113","author":"Ma","year":"2007","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib83","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1468-1331.2002.00421.x","article-title":"Does caffeine intake protect from Alzheimer's disease?","volume":"9","author":"Maia","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuint.2015.07.018_bib84","series-title":"On the Pharmacology of the New Alkaloid Galantamine","first-page":"27","author":"Mashkovsky","year":"1951"},{"issue":"1\u20132","key":"10.1016\/j.neuint.2015.07.018_bib85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2009.01.024","article-title":"Galantamine inhibits beta-amyloid aggregation and cytotoxicity","volume":"280","author":"Matharu","year":"2009","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib86","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3233\/JAD-143084","article-title":"Combination therapy of cholinesterase inhibitor (Donepezil or galantamine) plus memantine in the okayama memantine study","volume":"45","author":"Matsuzono","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib87","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1460-9568.2009.06612.x","article-title":"Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons","volume":"29","author":"Melo","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2015.07.018_bib88","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnint.2013.00059","article-title":"Inflammatory process in Alzheimer's Disease","volume":"7","author":"Meraz-R\u00edos","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuint.2015.07.018_bib89","series-title":"Encyclopedia of Physical Science and Technology \u2013 Alkaloids","author":"Meyers","year":"2002"},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib90","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","article-title":"APOE \u03b54: the most prevalent yet understudied risk factor for Alzheimer's disease","volume":"10","author":"Michaelson","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuint.2015.07.018_bib91","doi-asserted-by":"crossref","first-page":"309129","DOI":"10.1155\/2014\/309129","article-title":"Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs","volume":"2014","author":"Millington","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib92","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3233\/JAD-142148","article-title":"Predictive factors of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease and mixed dementia: a one-year naturalistic study","volume":"45","author":"Miranda","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib93","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2014.07.098","article-title":"Genomic aspects of sporadic neurodegenerative diseases","volume":"452","author":"Mitsui","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.neuint.2015.07.018_bib94","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1211\/0022357001777612","article-title":"Effects of Uncaria tomentosa total alkaloid and its components on experimental amnesia in mice: elucidation using the passive avoidance test","volume":"52","author":"Mohamed","year":"2000","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.neuint.2015.07.018_bib95","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"Morales","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuint.2015.07.018_bib96","series-title":"Alzheimer's Disease Medications Fact Sheet Alzheimer's Disease Medications Fact Sheet National Institutes of Health","author":"National Institute on Aging","year":"2015"},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib97","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0149-7634(98)00050-5","article-title":"Are we dependent upon coffee and caffeine? A review on human and animal data","volume":"23","author":"Nehlig","year":"1999","journal-title":"Neurosci. Biobehav Rev."},{"issue":"10","key":"10.1016\/j.neuint.2015.07.018_bib98","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/138955711796575434","article-title":"An overview on natural cholinesterase inhibitors\u2013a multi-targeted drug class\u2013and their mass production","volume":"11","author":"Orhan","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"issue":"7","key":"10.1016\/j.neuint.2015.07.018_bib99","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.neuint.2009.01.012","article-title":"Capsaicin promotes the amyloidogenic route of brain amyloid precursor protein processing","volume":"54","author":"P\u00e1k\u00e1ski","year":"2009","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5114\/aoms.2013.33354","article-title":"Effects of berberine on \u03b2-secretase activity in a rabbit model of Alzheimer's disease","volume":"9","author":"Panahi","year":"2013","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.neuint.2015.07.018_bib101","series-title":"Development of Reminyl (R) (Galantamine), a Novel Acetylcholinesterase Inhibitor, for the Treatment of Alzheimer's Disease,Alzheimer's Report","first-page":"S19","author":"Parys","year":"1998"},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.aat.2010.12.008","article-title":"Mu opioid receptors in pain management","volume":"49","author":"Pasternak","year":"2011","journal-title":"Acta Anaesthesiol. Taiwan"},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib103","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jnc.12304","article-title":"Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease","volume":"126","author":"Paula-Lima","year":"2013","journal-title":"J.\u00a0Neurochem."},{"issue":"7","key":"10.1016\/j.neuint.2015.07.018_bib104","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.freeradbiomed.2010.07.007","article-title":"Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet","volume":"49","author":"Prasanthi","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib105","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.4049\/jimmunol.179.2.1198","article-title":"Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity","volume":"179","author":"Qian","year":"2007","journal-title":"J.\u00a0Immunol."},{"issue":"17","key":"10.1016\/j.neuint.2015.07.018_bib106","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.bmc.2004.06.035","article-title":"Antiradical and antioxidant activities of alkaloids isolated from mahonia aquifolium. Structural aspects","volume":"12","author":"Rackov\u00e1","year":"2004","journal-title":"Bioorg Med. Chem."},{"issue":"16","key":"10.1016\/j.neuint.2015.07.018_bib107","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1212\/WNL.0b013e318216eb7b","article-title":"A\u00a0phase II trial of huperzine A in mild to moderate Alzheimer disease","volume":"76","author":"Rafii","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neuint.2015.07.018_bib108","first-page":"BR386","article-title":"Morphine modulation of the ubiquitin-proteasome complex is neuroprotective","volume":"11","author":"Rambhia","year":"2005","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nsb0197-57","article-title":"Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A","volume":"4","author":"Raves","year":"1997","journal-title":"Nat. Struct. Biol."},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/ane.12195","article-title":"Galantamine treatment in outpatients with mild Alzheimer's disease","volume":"129","author":"Richarz","year":"2014","journal-title":"Acta Neurol. Scand."},{"issue":"48","key":"10.1016\/j.neuint.2015.07.018_bib111","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","article-title":"DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease","volume":"282","author":"Ryoo","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib112","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2000.2.2\/lschneider","article-title":"A\u00a0critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease","volume":"2","author":"Schneider, L","year":"2000","journal-title":"Dialogues Clin. Neurosci."},{"issue":"42","key":"10.1016\/j.neuint.2015.07.018_bib113","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1021\/bi9617264","article-title":"Nicotine inhibits amyloid formation by the beta-peptide","volume":"35","author":"Salomon","year":"1996","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J.\u00a0Intern Med."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)08675-4","article-title":"Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands","volume":"49","author":"Schrattenholz","year":"1996","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuint.2015.07.018_bib116","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2165\/00003495-200060050-00008","article-title":"Galantamine: a review of its use in Alzheimer's disease","volume":"60","author":"Scott","year":"2000","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib117","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.bjp.0707471","article-title":"Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation","volume":"152","author":"Selenica","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib118","first-page":"2944","article-title":"Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer's disease","volume":"8","author":"Shao","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib119","first-page":"97","article-title":"Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline","volume":"24","author":"Shi","year":"2003","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"10.1016\/j.neuint.2015.07.018_bib120","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s11064-008-9629-5","article-title":"Nicotine leads to improvements in behavioral impairment and an increase in the nicotine acetylcholine receptor in transgenic mice","volume":"33","author":"Shim","year":"2008","journal-title":"Neurochem. Res."},{"issue":"Pt 5","key":"10.1016\/j.neuint.2015.07.018_bib121","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/brain\/awu046","article-title":"Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease","volume":"137","author":"Shinohara","year":"2014","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib122","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12272-013-0051-4","article-title":"Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"36","author":"Shin","year":"2013","journal-title":"Arch. Pharm. Res."},{"issue":"24","key":"10.1016\/j.neuint.2015.07.018_bib123","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1997.03540480021011","article-title":"Screening to help asthmatics breathe easier","volume":"277","author":"Skolnick","year":"1997","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.neuint.2015.07.018_bib124","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0278-6915(02)00096-0","article-title":"Effects of caffeine on human behavior","volume":"40","author":"Smith","year":"2002","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JAD-2010-1239","article-title":"Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment","volume":"19","author":"Smith","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2015.07.018_bib126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.conb.2014.02.003","article-title":"Beyond pathology: APP, brain development and Alzheimer's disease","volume":"27","author":"Soldano","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib127","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","article-title":"The evolution of preclinical Alzheimer's disease: implications for prevention trials","volume":"84","author":"Sperling","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2015.07.018_bib128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1326-9-51","article-title":"Models of \u03b2-amyloid induced Tau-pathology: the long and \u201cfolded\u201d road to understand the mechanism","volume":"9","author":"Stancu","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.neuint.2015.07.018_bib129","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/14786419.2014.980245","article-title":"Huperzine A production by paecilomyces tenuis YS-13, an endophytic fungus isolated from Huperzia serrata","volume":"29","author":"Su","year":"2015","journal-title":"Nat. Prod. Res."},{"issue":"18","key":"10.1016\/j.neuint.2015.07.018_bib130","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1016\/j.bmc.2013.07.011","article-title":"Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: inhibition of acetylcholinesterase, butyrylcholinesterase, and A\u03b2 aggregation and antioxidant activity","volume":"21","author":"Su","year":"2013","journal-title":"Bioorg Med. Chem."},{"issue":"1\u20133","key":"10.1016\/j.neuint.2015.07.018_bib131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2006.08.017","article-title":"Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity","volume":"549","author":"Takada-Takatori","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib132","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1745-7254.2005.00130.x","article-title":"Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells","volume":"26","author":"Tang","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2015.07.018_bib133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2005.06.026","article-title":"Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production","volume":"519","author":"Tang","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib134","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jnr.490240220","article-title":"Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat","volume":"24","author":"Tang","year":"1989","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-8741(94)01182-6","article-title":"Comparison of the effects of natural and synthetic huperzine-A on rat brain cholinergic function in\u00a0vitro and in\u00a0vivo","volume":"44","author":"Tang","year":"1994","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.neuint.2015.07.018_bib136","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00316106","article-title":"Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans","volume":"39","author":"Thomsen","year":"1990","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.neuint.2015.07.018_bib137","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0378-8741(03)00045-X","article-title":"In\u00a0vitro antiplasmodial activity of antimalarial medicinal plants used in vietnamese traditional medicine","volume":"86","author":"Tran","year":"2003","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib138","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3233\/JAD-2010-090667","article-title":"Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?","volume":"21","author":"Trepanier","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"36","key":"10.1016\/j.neuint.2015.07.018_bib139","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.2174\/09298673113209990148","article-title":"Antioxidant activity of galantamine and some of its derivatives","volume":"20","author":"Tsvetkova","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuint.2015.07.018_bib140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer's disease","volume":"9","author":"Tu","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib141","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ije\/23.3.495","article-title":"Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland","volume":"23","author":"Vartiainen","year":"1994","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib142","first-page":"27","article-title":"Anticholinesterase effects of huperzine A, E2020, and tacrine in rats","volume":"19","author":"Wang","year":"1998","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"8","key":"10.1016\/j.neuint.2015.07.018_bib143","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","article-title":"beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology","volume":"275","author":"Wang","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"issue":"12","key":"10.1016\/j.neuint.2015.07.018_bib144","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1097\/00001756-200108280-00009","article-title":"Huperzine A attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells","volume":"12","author":"Wang","year":"2001","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1745-7254.2006.00255.x","article-title":"Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib146","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(01)01030-5","article-title":"Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1-40) in rat","volume":"421","author":"Wang","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.neuint.2015.07.018_bib147","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.lfs.2005.02.033","article-title":"Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of coptidis rhizoma extract","volume":"77","author":"Wang","year":"2005","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib148","first-page":"31","article-title":"Modulation of NMDA receptor by huperzine A in rat cerebral cortex","volume":"20","author":"Wang","year":"1999","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib149","first-page":"110","article-title":"Anti-cholinesterase activity of huperzine A","volume":"7","author":"Wang","year":"1986","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.pbb.2006.03.027","article-title":"Effects of huperzine A on memory deficits and neurotrophic factors production after transient cerebral ischemia and reperfusion in mice","volume":"83","author":"Wang","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib151","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bcp.12621","article-title":"Emerging drug targets for A\u03b2 and tau in Alzheimer's disease: a systematic review","volume":"80","author":"West","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib152","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s002130050931","article-title":"Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease","volume":"143","author":"White","year":"1999","journal-title":"Psychopharmacol. Berl."},{"issue":"10","key":"10.1016\/j.neuint.2015.07.018_bib153","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00002512-200320100-00006","article-title":"A\u00a0long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease","volume":"20","author":"Wilcock","year":"2003","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib154","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1073\/pnas.98.4.2089","article-title":"Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning","volume":"98","author":"Woodruff-Pak","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2015.07.018_bib155","article-title":"The binding receptors of a\u03b2: an alternative therapeutic target for Alzheimer's disease","author":"Xia","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib156","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JAD-131457","article-title":"Isorhynchophylline treatment improves the amyloid-\u03b2-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation","volume":"39","author":"Xian","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2015.07.018_bib157","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/163057","article-title":"Isorhynchophylline protects PC12 cells against beta-amyloid-induced apoptosis via PI3K\/Akt signaling pathway","volume":"2013","author":"Xian","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.neuint.2015.07.018_bib158","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/802625","article-title":"Bioassay-guided Isolation of neuroprotective compounds from uncaria rhynchophylla against beta-amyloid-induced neurotoxicity","volume":"2012","author":"Xian","year":"2012","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib159","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10571-011-9763-5","article-title":"Protective effect of isorhynchophylline against \u03b2-amyloid-induced neurotoxicity in PC12 cells","volume":"32","author":"Xian","year":"2012","journal-title":"Cell Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jnr.10075","article-title":"Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation","volume":"67","author":"Xiao","year":"2002","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"7","key":"10.1016\/j.neuint.2015.07.018_bib161","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s10295-014-1461-0","article-title":"Efficient strategy for maintaining and enhancing the huperzine A production of Shiraia sp. Slf14 through inducer elicitation","volume":"41","author":"Yan","year":"2014","journal-title":"J.\u00a0Ind. Microbiol. Biotechnol."},{"issue":"9","key":"10.1016\/j.neuint.2015.07.018_bib162","doi-asserted-by":"crossref","first-page":"e74916","DOI":"10.1371\/journal.pone.0074916","article-title":"Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib163","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3233\/JAD-2012-120274","article-title":"Decreased accumulation of subcellular amyloid-\u03b2 with improved mitochondrial function mediates the neuroprotective effect of huperzine A","volume":"31","author":"Yang","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.neuint.2015.07.018_bib164","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1211\/jpp.61.07.0001","article-title":"Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research","volume":"61","author":"Ye","year":"2009","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-2011-101779","article-title":"Berberine attenuates calyculin A-induced cytotoxicity and Tau hyperphosphorylation in HEK293 cells","volume":"24","author":"Yu","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neuint.2015.07.018_bib166","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2011.08.036","article-title":"Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice","volume":"1417","author":"Zeitlin","year":"2011","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib167","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0306-4522(01)00206-8","article-title":"Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons","volume":"105","author":"Zhang","year":"2001","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib168","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00210-003-0854-9","article-title":"In\u00a0vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel)","volume":"369","author":"Zhang","year":"2004","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2015.07.018_bib169","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(01)02565-4","article-title":"Spermidine antagonizes the inhibitory effect of huperzine A on [3H]dizocilpine (MK-801) binding in synaptic membrane of rat cerebral cortex","volume":"319","author":"Zhang","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuint.2015.07.018_bib170","first-page":"452","article-title":"Protective effect of berberine on cardiac myocyte injured by ischemia-reperfusion","volume":"34","author":"Zheng","year":"2003","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"issue":"10","key":"10.1016\/j.neuint.2015.07.018_bib171","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1097\/00001756-200107200-00007","article-title":"Huperzine A protects rat pheochromocytoma cells against oxygen-glucose deprivation","volume":"12","author":"Zhou","year":"2001","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.neuint.2015.07.018_bib172","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jep.2010.08.041","article-title":"Antihypertensive and neuroprotective activities of rhynchophylline: the role of rhynchophylline in neurotransmission and ion channel activity","volume":"132","author":"Zhou","year":"2010","journal-title":"J.\u00a0Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.neuint.2015.07.018_bib173","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.fitote.2012.02.010","article-title":"Isorhynchophylline: a plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases","volume":"83","author":"Zhou","year":"2012","journal-title":"Fitoterapia"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018615300206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018615300206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:47:30Z","timestamp":1778676450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018615300206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":172,"alternative-id":["S0197018615300206"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2015.07.018","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plant alkaloids as drug leads for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2015.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}